{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:41:44Z","timestamp":1769971304275,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070422"],"award-info":[{"award-number":["81070422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070407"],"award-info":[{"award-number":["81070407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010084","name":"Independent Innovation Foundation of Shandong University","doi-asserted-by":"crossref","award":["2009TS071"],"award-info":[{"award-number":["2009TS071"]}],"id":[{"id":"10.13039\/501100010084","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical and Health Science Technology Development of Shandong Province, China","award":["2013WS0229"],"award-info":[{"award-number":["2013WS0229"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.cca.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T05:43:03Z","timestamp":1402983783000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The expression of VEGF and Dll4\/Notch pathway molecules in ovarian cancer"],"prefix":"10.1016","volume":"436","author":[{"given":"Hongchun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L ong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.06.005_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics,2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cca.2014.06.005_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cca.2014.06.005_bb0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3322\/canjclin.49.5.297","article-title":"Epithelial ovarian cancer: prevention, diagnosis, and treatment","volume":"49","author":"Partridge","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cca.2014.06.005_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/GCO.0b013e32831ffe71","article-title":"New therapeutic agents in ovarian cancer","volume":"21","author":"Collinson","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.cca.2014.06.005_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ncponc1051","article-title":"Angiogenesis as a strategic target for ovarian cancer therapy","volume":"5","author":"Spannuth","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2006.08.8583","article-title":"Tumor vascular proteins as biomarkers in ovarian cancer","volume":"25","author":"Buckanovich","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.critrevonc.2011.09.006","article-title":"Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms","volume":"83","author":"Bellati","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cca.2014.06.005_bb0040","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2009.08.032","article-title":"Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer","volume":"115","author":"Hurt","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1200\/JCO.2009.23.7537","article-title":"Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2","volume":"28","author":"Spratlin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tcb.2006.04.003","article-title":"Notch signaling in the regulation of tumor angiogenesis","volume":"16","author":"Rehman","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.cca.2014.06.005_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/MCB.23.1.14-25.2003","article-title":"Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis","volume":"23","author":"Liu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cca.2014.06.005_bb0060","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1158\/0008-5472.CAN-10-2719","article-title":"Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer","volume":"71","author":"Hu","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2008.11.030","article-title":"Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: a Gynecologic Oncology Group study","volume":"112","author":"Rubatt","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00666038","article-title":"Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors","volume":"36","author":"Weidner","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cca.2014.06.005_bb0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cca.2014.06.005_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","article-title":"VEGF-A and the induction of pathological angiogenesis","volume":"2","author":"Nagy","year":"2007","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.cca.2014.06.005_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2014.06.005_bb0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2014.06.005_bb0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2014.06.005_bb0100","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","article-title":"The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis","volume":"271","author":"Clauss","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2014.06.005_bb0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","article-title":"Vascular endothelial growth factor expression in early stage ovarian carcinoma","volume":"80","author":"Paley","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2014.06.005_bb0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clinbiochem.2004.01.014","article-title":"Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients","volume":"37","author":"Kassim","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2014.06.005_bb0115","first-page":"3193","article-title":"Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer","volume":"8","author":"Cooper","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0120","first-page":"1973","article-title":"Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer","volume":"24","author":"Li","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ygyno.2006.03.058","article-title":"Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer","volume":"103","author":"Hefler","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0130","first-page":"641","article-title":"Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer","volume":"29","author":"Kuemmel","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2008.11.013","article-title":"Markers of angiogenesis in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study","volume":"112","author":"Randall","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0140","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ygyno.2004.05.056","article-title":"VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma","volume":"94","author":"Chen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0145","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ygyno.2006.10.062","article-title":"Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies","volume":"104","author":"Frumovitz","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.06.005_bb0150","first-page":"831","article-title":"Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2","volume":"15","author":"Zhang","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cca.2014.06.005_bb0155","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.2741\/3438","article-title":"Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications","volume":"14","author":"Li","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.cca.2014.06.005_bb0160","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.bjc.6604484","article-title":"VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis","volume":"99","author":"Thurston","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cca.2014.06.005_bb0165","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/embor.2011.194","article-title":"Endothelial basement membrane limits tip cell formation by inducing Dll4\/Notch signalling in vivo","volume":"12","author":"Stenzel","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/j.cca.2014.06.005_bb0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.RES.0000254788.47304.6e","article-title":"Critical role of endothelial Notch1 signaling in postnatal angiogenesis","volume":"100","author":"Takeshita","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/01.ATV.0000060892.81529.8F","article-title":"Notch signaling in vascular development","volume":"23","author":"Iso","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2014.06.005_bb0180","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1038\/onc.2008.227","article-title":"Notch signaling regulates tumor angiogenesis by diverse mechanisms","volume":"27","author":"Dufraine","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2014.06.005_bb0185","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04480","article-title":"Lymphangiogenesis in development and human disease","volume":"438","author":"Alitalo","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cca.2014.06.005_bb0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng1099","article-title":"Notch1 functions as a tumor suppressor in mouse skin","volume":"33","author":"Nicolas","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2014.06.005_bb0195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bjc.6602719","article-title":"The Notch pathway in ovarian carcinomas and adenomas","volume":"93","author":"Hopfer","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cca.2014.06.005_bb0200","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1158\/0008-5472.CAN-05-1208","article-title":"Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function","volume":"65","author":"Patel","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0205","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1158\/0008-5472.CAN-05-4226","article-title":"The role of the vascular endothelial growth factor-Delta-like 4 ligand\/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions","volume":"66","author":"Hainaud","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nature05313","article-title":"Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis","volume":"444","author":"Ridgway","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cca.2014.06.005_bb0215","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis","volume":"445","author":"Hellstrom","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cca.2014.06.005_bb0220","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1073\/pnas.0611206104","article-title":"Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting","volume":"104","author":"Lobov","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2014.06.005_bb0225","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1073\/pnas.0611177104","article-title":"The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching","volume":"104","author":"Suchting","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2014.06.005_bb0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/mvre.2002.2443","article-title":"Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2\/KDR expression","volume":"64","author":"Taylor","year":"2002","journal-title":"Microvasc Res"},{"key":"10.1016\/j.cca.2014.06.005_bb0235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mvr.2007.06.006","article-title":"Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells","volume":"75","author":"Harrington","year":"2008","journal-title":"Microvasc Res"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:53:22Z","timestamp":1589230402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":47,"alternative-id":["S0009898114002630"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.06.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression of VEGF and Dll4\/Notch pathway molecules in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}